MedTrace Logo

Open-label Study to Evaluate the Effect of MBP-80 on Bone Remodelling

NCT01501344 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 50

Last updated 2012-01-09

No results posted yet for this study

Summary

This study will determine if daily oral intake of 200g of a marketed yogurt with fortified calcium content and a milk basic protein (MBP)80 mg benefits on bone cells activity in postmenopausal women. The efficacy of the product is measured by examining the variation of biochemical markers of bone turnover. MBP 80 is a particular protein contained in milk; it has been added to the yogurt provided for this study. The effects of MBP 80 on the quality of bone tissue have not yet been proven.

Conditions

  • Postmenopausal Osteoporosis

Interventions

DIETARY_SUPPLEMENT

200 g yogurt with fortified calcium content and MBP 80 mg

Intake of one container of vanilla or strawberry yogurt in the morning on a daily basis during 12 weeks.

Sponsors & Collaborators

  • Aliments ULTIMA Foods Inc.

    collaborator INDUSTRY

  • Groupe De Recherche En Rhumatologie Et Maladies Osseuses Inc.

    lead INDUSTRY

Principal Investigators

  • Jacques P Brown, M.D. · G.R.M.O. Inc.

Study Design

Allocation
NA
Purpose
PREVENTION
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
45 Years
Max Age
60 Years
Sex
FEMALE
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2011-01-31
Primary Completion
2011-08-31
Completion
2011-08-31

Countries

  • Canada

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01501344 on ClinicalTrials.gov